Drug-Induced Immune Thrombocytopenia Caused by Sulfamethoxazole-Trimethoprim: A Case Report

Introduction: Drug-induced immune thrombocytopenia (DITP) is a rare process in which specific drugs induce antibodies against platelet antigens, resulting in the destruction, consumption, or impaired production of platelets.1,3 Sulfamethoxazole-trimethoprim can result in DITP.2 Case Report: This is a case of a 64-year-old man who developed severe thrombocytopenia after sulfamethoxazole-trimethoprim use. He presented to the emergency department with oral hemorrhagic lesions, mucositis, and petechiae. Laboratory evaluation revealed a low platelet count. Drug-induced immune thrombocytopenia was suspected, and the sulfamethoxazole-trimethoprim was discontinued. The patient’s platelet count responded rapidly after discontinuation of the offending drug and administration of dexamethasone. Conclusion: This case highlights the importance of early recognition of DITP and the avoidance of re-exposure to the causative agent. Prompt drug withdrawal and adjunctive corticosteroid therapy can facilitate complete clinical recovery.

Authors

Publication Details

Journal
Clinical Practice and Cases in Emergency Medicine
Published
2026-10-31
DOI
https://doi.org/10.5811/cpcem.65094
Primary Topic
Platelet Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Drug-Induced Immune Thrombocytopenia Caused by Sulfamethoxazole-Trimethoprim: A Case Report

Louisa Weindruch, Alec Powell, Jonathan Thornton
Clinical Practice and Cases in Emergency Medicine
Platelet Disorders and Treatments
article

Drug-Induced Immune Thrombocytopenia Caused by Sulfamethoxazole-Trimethoprim: A Case Report

Louisa Weindruch, Alec Powell, Jonathan Thornton
article en

Abstract

Introduction: Drug-induced immune thrombocytopenia (DITP) is a rare process in which specific drugs induce antibodies against platelet antigens, resulting in the destruction, consumption, or impaired production of platelets.1,3 Sulfamethoxazole-trimethoprim can result in DITP.2 Case Report: This is a case of a 64-year-old man who developed severe thrombocytopenia after sulfamethoxazole-trimethoprim use. He presented to the emergency department with oral hemorrhagic lesions, mucositis, and petechiae. Laboratory evaluation revealed a low platelet count. Drug-induced immune thrombocytopenia was suspected, and the sulfamethoxazole-trimethoprim was discontinued. The patient’s platelet count responded rapidly after discontinuation of the offending drug and administration of dexamethasone. Conclusion: This case highlights the importance of early recognition of DITP and the avoidance of re-exposure to the causative agent. Prompt drug withdrawal and adjunctive corticosteroid therapy can facilitate complete clinical recovery.

Clinical Practice and Cases in Emergency MedicineVol. 0(0)
Openalex Percentile: Top 11%
Platelet Disorders and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
Drug-Induced Immune Thrombocytopenia Caused by Sulfamethoxazole-Trimethoprim: A Case Report — Louisa Weindruch, Alec Powell, et al. · Clinical Practice and Cases in Emergency Medicine (2026) | TGRS Research Map | TGRS